Trial Profile
Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes [Switch da clopidogrel a prasugrel per migliorare il trattamento precocemente invasivo delle sindromi coronariche acute].
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Coronary artery disease
- Focus Pharmacodynamics
- Acronyms SWITCH-OVER
- 24 Sep 2012 New trial record